Modafinil for the Treatment of Cocaine Dependence - 1

National Institute on Drug Abuse (NIDA)210 enrolled

Overview

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Study Type

INTERVENTIONAL

Purpose

DIAGNOSTIC

Enrollment

210

Conditions

Cocaine-Related Disorders

Interventions

ModafinilDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID. * Must be seeking treatment for cocaine dependence. * Must be able to understand and provide written informed consent. Exclusion Criteria: * Please contact the study site for more information.

Locations (6)

Boston University Medical Center

Boston, Massachusetts, United States

New York VA Medical Center

New York, New York, United States

Cincinnati Addiction Research Center

Cincinnati, Ohio, United States

Western Psychiatric Institute & Clinic

Pittsburgh, Pennsylvania, United States

Outcomes

Primary Outcomes

Cocaine abstinence

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.